OTCMKTS:MYMX Mymetics (MYMX) Stock Price, News & Analysis → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free MYMX Stock Alerts $0.01 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$0.01▼$0.0150-Day Range$0.01▼$0.0152-Week Range$0.01▼$70.00Volume1 shsAverage Volume3 shsMarket Capitalization$1,500.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsStock AnalysisChartEarningsFinancialsSEC Filings Get Mymetics alerts: Email Address Ad WealthPressHow this is some devastating newsCheck out this report real quick… It’s full proof that most people barely have enough money to cover the monthly expenditures… Let alone save for retirement or plan the next vacation. At the risk of sounding political… If you’re waiting for the Fed, or the government or some financial advisor to come to change things for the better… You might be waiting for a long long time. But what if…? What if there was a way to completely turn the tables?But I can promise that you’ll see all the details for yourself here. About MymeticsMymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.Read More MYMX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MYMX Stock News HeadlinesMarch 29, 2024 | seekingalpha.comPLTXF PlantX Life Inc.February 2, 2024 | finance.yahoo.comMymetics Corporation (MYMXD) Stock Historical Prices & Data - Yahoo FinanceDecember 31, 2023 | benzinga.comMymetics Stock (OTC:MYMX) Dividends: History, Yield and DatesMarch 1, 2023 | lse.co.ukOriole Resources project in Cameroon delivers high-grade gold resultsNovember 16, 2022 | benzinga.comMymetics Stock (OTC:MYMX), Short Interest ReportOctober 11, 2022 | finance.yahoo.comMymetics Corporation (MYMX)September 1, 2022 | seekingalpha.comMymetics, PCI Biotech team up for preclinical research on cancer therapySeptember 1, 2022 | finanznachrichten.deMymetics Corporation: Mymetics and PCI Biotech Sign a Preclinical Research CollaborationAugust 31, 2022 | finance.yahoo.comMymetics and PCI Biotech Sign a Preclinical Research CollaborationAugust 25, 2022 | reuters.comMYMX.PK - Mymetics Corp | Stock Price & Latest News | ReutersSee More Headlines Receive MYMX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mymetics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolOTCMKTS:MYMX CUSIPN/A CIK927761 Webwww.mymetics.com Phone(121) 653-4535Fax41-21-653-2473Employees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,060,000.00 Net Margins-1,914.40% Pretax Margin-1,917.46% Return on EquityN/A Return on Assets-128.84% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.08 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.23) per share Price / Book-0.04Miscellaneous Outstanding Shares150,000Free Float144,000Market Cap$1,500.00 OptionableNot Optionable Beta1.64 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Ronald Kempers (Age 56)CEO, COO, President & CFO Comp: $303.83kMr. Mario Amacker Ph.D.Head of Quality & ManufacturingKey CompetitorsAdvanced Life SciencesOTCMKTS:ADLSAlvotechNYSE:ALVOAVAX TechnologiesOTCMKTS:AVXTClarus TherapeuticsOTCMKTS:CRXTQEnzon PharmaceuticalsOTCMKTS:ENZNView All Competitors MYMX Stock Analysis - Frequently Asked Questions How have MYMX shares performed in 2024? Mymetics' stock was trading at $0.0020 at the beginning of the year. Since then, MYMX stock has increased by 400.0% and is now trading at $0.01. View the best growth stocks for 2024 here. What other stocks do shareholders of Mymetics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Mymetics investors own include Genocea Biosciences (GNCA), Dynavax Technologies (DVAX), Fujitsu (FJTSY), Himax Technologies (HIMX), Maxar Technologies (MAXR), Revance Therapeutics (RVNC), Boeing (BA), Activision Blizzard (ATVI), Asure Software (ASUR) and Arlo Technologies (ARLO). How do I buy shares of Mymetics? Shares of MYMX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MYMX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaUrgent Nvidia WarningAltimetryNext President (Not Trump. Not Biden.)The Freeport SocietyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mymetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.